Home > Publications database > Khasianine Affects the Expression of Sugar-Sensitive Proteins in Pancreatic Cancer Cells, Which Are Altered in Data from the Rat Model and Patients > print

001     275916
005     20240918112604.0
024 7 _ |a 10.1021/acsptsci.3c00013
|2 doi
037 _ _ |a DKFZ-2023-00904
082 _ _ |a 610
100 1 _ |a Sagini, Micah N.
|0 0000-0002-3934-2468
|b 0
|e First author
245 _ _ |a Khasianine Affects the Expression of Sugar-Sensitive Proteins in Pancreatic Cancer Cells, Which Are Altered in Data from the Rat Model and Patients
260 _ _ |a Washington, DC
|c 2023
|b ACS Publications
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726651529_5616
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:G401#LA:G401# / 2023 Apr 13;6(5):727-737 / Owen Biochemistry and Biomarkers Unit
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Klika, Karel D.
|0 P:(DE-He78)c53db83479d3d1265967405af71f69bb
|b 1
|u dkfz
700 1 _ |a Owen, Robert
|0 P:(DE-He78)43996fb100428b0d99e233c3261f7187
|b 2
700 1 _ |a Berger, Martin
|0 P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676
|b 3
|e Last author
773 _ _ |a 10.1021/acsptsci.3c00013
|g p. acsptsci.3c00013
|0 PERI:(DE-600)2934670-8
|n 5
|p 727-737
|t ACS pharmacology & translational science
|v 6
|y 2023
|x 2575-9108
909 C O |p VDB
|o oai:inrepo02.dkfz.de:275916
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 0000-0002-3934-2468
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)c53db83479d3d1265967405af71f69bb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)43996fb100428b0d99e233c3261f7187
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)7e60033e3eaaebb9ba30c905ade4a676
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-15
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACS PHARMACOL TRANSL : 2022
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-27
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ACS PHARMACOL TRANSL : 2022
|d 2023-10-27
920 2 _ |0 I:(DE-He78)G401-20160331
|k G401
|l Molekulare Toxikologie und Chemotherapie
|x 0
920 1 _ |0 I:(DE-He78)G401-20160331
|k G401
|l Molekulare Toxikologie und Chemotherapie
|x 0
920 1 _ |0 I:(DE-He78)A390-20160331
|k A390
|l AG Wirkstoffforschung
|x 1
920 0 _ |0 I:(DE-He78)G401-20160331
|k G401
|l Molekulare Toxikologie und Chemotherapie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G401-20160331
980 _ _ |a I:(DE-He78)A390-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21